MD Anderson Cancer Center shared a post on X:
“Research led by Dr. Katy Rezvani found that the addition of CD28, a molecule that is normally absent in mature NK cells, can enhance CAR NK function in blood and solid tumors.
Read how this could enhance NK cell therapies here.”
Source: MD Anderson Cancer Center/X